# FDA Inspection 1122018 - South Texas Blood & Tissue Center - February 20, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/3cf6a671-4c66-43f4-9bcd-b2c367877879
Source feed: FDA_Inspections

> FDA Inspection 1122018 for South Texas Blood & Tissue Center on February 20, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122018
- Company Name: South Texas Blood & Tissue Center
- Inspection Date: 2020-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279560 - 2025-08-14](https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/eb0b438b-63e2-4a2c-862f-51cdae99b320)
- [FDA Inspection 1279560 - 2025-08-14](https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/8e0d7857-853d-4436-9291-9528f3073943)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/522679bf-3e12-42e5-9053-63b312cedb3e)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/1a5b5ca5-6175-4c1d-a80b-9f23645ef37b)
- [FDA Inspection 1172990 - 2022-06-09](https://www.globalkeysolutions.net/records/fda_inspections/south-texas-blood-tissue-center/23534f60-e9d9-4c33-a4c5-866e619ae006)

Company: https://www.globalkeysolutions.net/companies/south-texas-blood-tissue-center/f300c449-57f5-4e4b-b1b9-1ed80dc00c7e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d